Spine Ablation in 2023: Indications, Goals, Guidelines, Evidence, an…

Jason Levy

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Br…

2024 ASCO® Annual Meeting Insights Hub

M. Bhave

Identifying Breast Cancer Subtypes and Recurrence Risk: Multigene As…

Han-Byoel Lee

Young Women With HR+/HER2- Breast Cancer: Options for Risk Assessment

University of Colorado Cancer Center

V. Borges

Neoadjuvant Chemo-IO for HR+/HER2- BC

Erin Cobain

Breast Imaging and the Young Patient

Cleveland Clinic Taussig Cancer Institute

L. Dean

Prognostic Roles of AMH and ctDNA Detection in HR+/HER2- Node+ eBC

Aurelio Castrellon

The Importance of Molecular Testing in HR+/HER2- mBC

UNC Lineberger Comprehensive Cancer Center

Y. Abdou

Interventional Breast Imaging: US, Stereo & MRI

Houston Methodist

L. Venta

Estrogen Receptor-Targeted PET Imaging: Clinical Applications and In…

Keck School of Medicine of USC

G. Ulaner

ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detectio…

2024 ESMO Annual Meeting Insights Hub

M. Ignatiadis

Cryoablation: The Memorial Sloan Kettering Experience

Houston Methodist

Y. Bryce

Treatment Approaches in Bone Metastases Pain Management

Francesco Massari

Novel Approaches in Oncology: Early Interception & BRCA Advances in …

Houston Methodist

P. Munster

Management of Breast Cancer Patients With BRCA1/2 Mutation

UChicago Medicine 12th International Clinical Cancer Genomics Conference

S. Narod

SABCS 2023 Insights: "Innovative Approaches at the Diagnosis and Tre…

Insights from 2023 SABCS

J. Mouabbi

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebrospin…

Insights from 2023 SABCS

L. Huppert

Cryoablation: Abscopal Effect and Immune Therapy

Houston Methodist

R. Ward